Literature DB >> 8417122

Human serum amyloid P component oligomers bind and activate the classical complement pathway via residues 14-26 and 76-92 of the A chain collagen-like region of C1q.

S C Ying1, A T Gewurz, H Jiang, H Gewurz.   

Abstract

Serum amyloid P component (SAP) was polymerized using the cleavable cross-linker 3,3'-dithio-bis-(sulfo-succinimidylpropionate) to study its interaction with the C system. Dimers and trimers, but no larger oligomers, were observed; the trimers retained native SAP immunoreactivity (except for one calcium-dependent epitope) without displaying neo-SAP epitopes. The SAP trimers bound strongly to C1q, at the level of the collagen-like region (CLR). SAP bound to synthetic C1q A chain peptides 14-26 and 76-92, and these peptides inhibited the binding of SAP trimers to the CLR. When incubated in dilute human serum, SAP trimers consumed total C and C4, but not alternative pathway, hemolytic activities. Consumption of C4 by SAP trimers was inhibited by C1q A chain peptide 14-26. Thus, SAP oligomers bind C1q and activate the classical C pathway via the collagen-like region of C1q, at sites located within residues 14-26 and/or 76-92 of the C1q A chain.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8417122

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  Serum amyloid P component bound to gram-negative bacteria prevents lipopolysaccharide-mediated classical pathway complement activation.

Authors:  C J de Haas; E M van Leeuwen; T van Bommel; J Verhoef; K P van Kessel; J A van Strijp
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 2.  Local neuroinflammation and the progression of Alzheimer's disease.

Authors:  Patrick L McGeer; Edith G McGeer
Journal:  J Neurovirol       Date:  2002-12       Impact factor: 2.643

3.  Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragment.

Authors:  Hee Young Hwang; Marcus R Duvall; Stephen Tomlinson; Robert J Boackle
Journal:  Mol Immunol       Date:  2008-03-03       Impact factor: 4.407

4.  Development of a humanized C1q A chain knock-in mouse: assessment of antibody independent beta-amyloid induced complement activation.

Authors:  Ming Li; Rahasson R Ager; Deborah A Fraser; Natalia O Tjokro; Andrea J Tenner
Journal:  Mol Immunol       Date:  2008-04-08       Impact factor: 4.407

5.  C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms.

Authors:  L E Leigh; B Ghebrehiwet; T P Perera; I N Bird; P Strong; U Kishore; K B Reid; P Eggleton
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

6.  Application of MS-based proteomics to study serum protein adsorption/absorption and complement C3 activation on poly(ethylene glycol) hydrogels.

Authors:  Xintong Wang; David R Schmidt; Evan J Joyce; W John Kao
Journal:  J Biomater Sci Polym Ed       Date:  2011       Impact factor: 3.517

7.  Interactions of complement proteins C1q and factor H with lipid A and Escherichia coli: further evidence that factor H regulates the classical complement pathway.

Authors:  Lee Aun Tan; Andrew C Yang; Uday Kishore; Robert B Sim
Journal:  Protein Cell       Date:  2011-05-15       Impact factor: 14.870

8.  Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques.

Authors:  Chiara Mencarelli; Gerard H Bode; Mario Losen; Mahesh Kulharia; Peter C Molenaar; Robert Veerhuis; Harry W M Steinbusch; Marc H De Baets; Gerry A F Nicolaes; Pilar Martinez-Martinez
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

9.  Binding of pentraxins to different nuclear structures: C-reactive protein binds to small nuclear ribonucleoprotein particles, serum amyloid P component binds to chromatin and nucleoli.

Authors:  M B Pepys; S E Booth; G A Tennent; P J Butler; D G Williams
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

10.  Human SAP is a novel peptidoglycan recognition protein that induces complement-independent phagocytosis of Staphylococcus aureus.

Authors:  Jang-Hyun An; Kenji Kurokawa; Dong-Jun Jung; Min-Jung Kim; Chan-Hee Kim; Yukari Fujimoto; Koichi Fukase; K Mark Coggeshall; Bok Luel Lee
Journal:  J Immunol       Date:  2013-08-21       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.